A software infrastructure company with a Rule of 40 score of 49, free cash flow running at more than twice net income, and a PEG of 0.15 trades 40% below the consensus price target at a 5.7-to-1 reward/risk ratio; the primary obstacle is a confirmed price downtrend — moving averages have crossed bearishly with a declining slope — that blocks entry until a technical reversal materializes.
Thesis pillars
- Growth Priced At Steep Discount→Stable
- Clean Earnings Delivery Record→Stable
- Confirmed Price Downtrend Death Cross→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026· older than 90 days
Cellebrite DI Ltd. (CLBT) Stock Analysis
Recovery setup
Technology · Software - Infrastructure
Sell if holding. At $12.43, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; Sector modifier (Technology): -0.8.
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt,... Read more
Sell if holding. At $12.43, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; Sector modifier (Technology): -0.8. Chart setup: Death cross but MACD improving, RSI 70. Score 6.0/10, moderate confidence.
Passes 6/10 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.
Recent developments
No fresh coverage since Oct 21, 2026
Recent Developments — Cellebrite DI Ltd.
Latest news
- NEWS Cellebrite Announces Autumn 2026 Product Release Featuring 'Genesis' AI Solution — fiscal.ai Oct 21, 2026 positive
- NEWS Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026 — fiscal.ai Oct 20, 2026
- NEWS Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15 — benzinga Aug 14, 2026 positive
- NEWS JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16 — benzinga Aug 14, 2026 neutral
- NEWS Earnings Flash (CLBT) Cellebrite DI Ltd. Posts Q2 Adjusted EPS $0.11 per Share, vs. FactSet Est of $0.11 - marketscreene — marketscreener.com Aug 13, 2026 neutral
Latest item Oct 21, 2026 · Generated 2026-11-05T11:39:29Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $12.43, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.5%; Sector modifier (Technology): -0.8. Chart setup: Death cross but MACD improving, RSI 70. Prior stop was $11.63. Score 6.0/10, moderate confidence.
Analyst target: $13.36 (+7.5% upside). Prior stop was $11.63. Stop-loss: $11.63.
Thin upside margin: 7.5%; Sector modifier (Technology): -0.8; Earnings in 6 days (event risk).
Cellebrite DI Ltd. trades at a P/E of 54.0 (forward 19.0). TrendMatrix value score: 5.7/10. Verdict: Sell.
15 analysts rate CLBT, with a consensus score of 4.2/5. 7 analysts publish price targets averaging $15.
What does Cellebrite DI Ltd. do?Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East,...
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.